SarakalimAlternative Names: BIIX1XX; RS 91309
Latest Information Update: 07 Aug 2014
At a glance
- Originator Roche Palo Alto LLC
- Developer Boehringer Ingelheim; Roche Palo Alto
- Class Benzopyrans; Muscle relaxants; Small molecules
- Mechanism of Action Potassium channel agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Asthma